Literature DB >> 27984525

Temporal change in headache and its contribution to the risk of developing first-onset temporomandibular disorder in the Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA) study.

Inna E Tchivileva1,2, Richard Ohrbach3, Roger B Fillingim4, Joel D Greenspan5,6, William Maixner7,8, Gary D Slade1,9.   

Abstract

While cross-sectional studies have demonstrated an association between headache and temporomandibular disorder (TMD), whether headache can predict the onset of TMD is unknown. The aims of this study were to evaluate the contribution of headache to the risk of developing TMD and describe patterns of change in headache types over time. An initially TMD-free cohort of 2410 persons with low frequency of headache completed quarterly questionnaires assessing TMD and headache symptoms over a median 3.0-year follow-up period. First-onset TMD was confirmed by clinical examination in 199 participants. Baseline reports of migraine (hazard ratio [HR] = 1.67, 95% confidence interval [CI]: 1.06-2.62) or mixed headache types (HR = 4.11, 95% CI: 1.47-11.46), or headache frequency (HR = 2.13, 95% CI: 1.31-3.48) predicted increased risk of developing TMD. In addition, headache dynamics across the follow-up period before the TMD onset were evaluated in a nested case-control study where 248 incident TMD cases were matched to 191 TMD-free controls. Both headache prevalence and frequency increased across the observation period among those who developed TMD but not among controls. Patients with TMD were more likely to experience worsening in the headache type compared with that by controls, eg, prevalence of definite migraine among TMD cases increased 10-fold. Among all headache types experienced by patients with TMD before the TMD onset, migraine had the highest odds of progression relative to remission (odds ratio = 2.8, 95% CI: 1.6-4.8), whereas for controls this ratio was significant only for the tension-type headache (odds ratio = 2.1, 95% CI: 1.2-3.9). The important clinical implication of these findings is that adequate treatment of migraine may reduce the risk for developing TMD.

Entities:  

Mesh:

Year:  2017        PMID: 27984525      PMCID: PMC5639910          DOI: 10.1097/j.pain.0000000000000737

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  59 in total

1.  THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION?

Authors:  A B HILL
Journal:  Proc R Soc Med       Date:  1965-05

2.  Prognosis of migraine and tension-type headache: a population-based follow-up study.

Authors:  Ann Christine Lyngberg; Birthe Krogh Rasmussen; Torben Jørgensen; Rigmor Jensen
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

3.  Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†.

Authors:  Eric Schiffman; Richard Ohrbach; Edmond Truelove; John Look; Gary Anderson; Jean-Paul Goulet; Thomas List; Peter Svensson; Yoly Gonzalez; Frank Lobbezoo; Ambra Michelotti; Sharon L Brooks; Werner Ceusters; Mark Drangsholt; Dominik Ettlin; Charly Gaul; Louis J Goldberg; Jennifer A Haythornthwaite; Lars Hollender; Rigmor Jensen; Mike T John; Antoon De Laat; Reny de Leeuw; William Maixner; Marylee van der Meulen; Greg M Murray; Donald R Nixdorf; Sandro Palla; Arne Petersson; Paul Pionchon; Barry Smith; Corine M Visscher; Joanna Zakrzewska; Samuel F Dworkin
Journal:  J Oral Facial Pain Headache       Date:  2014

4.  Brain stem activation in spontaneous human migraine attacks.

Authors:  C Weiller; A May; V Limmroth; M Jüptner; H Kaube; R V Schayck; H H Coenen; H C Diener
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

5.  Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain.

Authors:  W Maixner; R Fillingim; D Booker; A Sigurdsson
Journal:  Pain       Date:  1995-12       Impact factor: 6.961

6.  Influence of headache frequency on clinical signs and symptoms of TMD in subjects with temple headache and TMD pain.

Authors:  Gary C Anderson; Mike T John; Richard Ohrbach; Donald R Nixdorf; Eric L Schiffman; Edmond S Truelove; Thomas List
Journal:  Pain       Date:  2010-12-31       Impact factor: 6.961

7.  Sensitization of trigeminal nociception specific for migraine but not pain of sinusitis.

Authors:  Z Katsarava; G Lehnerdt; B Duda; J Ellrich; H C Diener; H Kaube
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

Review 8.  Headaches and sleep disorders.

Authors:  Thomas Freedom
Journal:  Dis Mon       Date:  2015-05-04       Impact factor: 3.800

9.  Psychological factors associated with development of TMD: the OPPERA prospective cohort study.

Authors:  Roger B Fillingim; Richard Ohrbach; Joel D Greenspan; Charles Knott; Luda Diatchenko; Ronald Dubner; Eric Bair; Cristina Baraian; Nicole Mack; Gary D Slade; William Maixner
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

10.  Predictors of onset of facial pain and temporomandibular disorders in early adolescence.

Authors:  Linda LeResche; Lloyd A Mancl; Mark T Drangsholt; Greg Huang; Michael Von Korff
Journal:  Pain       Date:  2006-11-28       Impact factor: 7.926

View more
  10 in total

Review 1.  Interplay of Oral, Mandibular, and Facial Disorders and Migraine.

Authors:  Antonia Teruel; Marcela Romero-Reyes
Journal:  Curr Pain Headache Rep       Date:  2022-05-14

2.  Preclinical studies investigating the neural mechanisms involved in the co-morbidity of migraine and temporomandibular disorders: the role of CGRP.

Authors:  Simon Akerman; Marcela Romero-Reyes
Journal:  Br J Pharmacol       Date:  2020-10-21       Impact factor: 8.739

Review 3.  Co-occurrence of pain syndromes.

Authors:  Giannapia Affaitati; Raffaele Costantini; Claudio Tana; Francesco Cipollone; Maria Adele Giamberardino
Journal:  J Neural Transm (Vienna)       Date:  2019-11-29       Impact factor: 3.575

4.  Clinical, psychological, and sensory characteristics associated with headache attributed to temporomandibular disorder in people with chronic myogenous temporomandibular disorder and primary headaches.

Authors:  Inna E Tchivileva; Richard Ohrbach; Roger B Fillingim; Feng-Chang Lin; Pei Feng Lim; Samuel J Arbes; Gary D Slade
Journal:  J Headache Pain       Date:  2021-05-22       Impact factor: 7.277

5.  Efficacy and safety of propranolol for treatment of temporomandibular disorder pain: a randomized, placebo-controlled clinical trial.

Authors:  Inna E Tchivileva; Holly Hadgraft; Pei Feng Lim; Massimiliano Di Giosia; Margarete Ribeiro-Dasilva; John H Campbell; Janet Willis; Robert James; Marcus Herman-Giddens; Roger B Fillingim; Richard Ohrbach; Samuel J Arbes; Gary D Slade
Journal:  Pain       Date:  2020-08       Impact factor: 7.926

6.  Prevalence of Painful Temporomandibular Disorders and Correlation to Lifestyle Factors among Adolescents in Norway.

Authors:  Vegard Østensjø; Ketil Moen; Trond Storesund; Annika Rosén
Journal:  Pain Res Manag       Date:  2017-05-30       Impact factor: 3.037

Review 7.  Genetic overlap between temporomandibular disorders and primary headaches: A systematic review.

Authors:  Diogo Cruz; Francisca Monteiro; Maria Paço; Manuel Vaz-Silva; Carolina Lemos; Miguel Alves-Ferreira; Teresa Pinho
Journal:  Jpn Dent Sci Rev       Date:  2022-02-23

8.  The Chinese version of the Oral Health Impact Profile-14 (OHIP-14) questionnaire among college students: factor structure and measurement invariance across genders.

Authors:  Yao Feng; Jing-Jie Lu; Ze-Yue Ouyang; Lan-Xin Xue; Tan Li; Yun Chen; Zheng-Rong Gao; Shao-Hui Zhang; Jie Zhao; Ya-Qiong Zhao; Qin Ye; Jing Hu; Yun-Zhi Feng; Yue Guo
Journal:  BMC Oral Health       Date:  2022-09-17       Impact factor: 3.747

9.  Effect of comorbid migraine on propranolol efficacy for painful TMD in a randomized controlled trial.

Authors:  Inna E Tchivileva; Richard Ohrbach; Roger B Fillingim; Pei Feng Lim; Massimiliano Di Giosia; Margarete Ribeiro-Dasilva; John H Campbell; Holly Hadgraft; Janet Willis; Samuel J Arbes; Gary D Slade
Journal:  Cephalalgia       Date:  2021-02-09       Impact factor: 6.292

10.  A Pre-Existing Myogenic Temporomandibular Disorder Increases Trigeminal Calcitonin Gene-Related Peptide and Enhances Nitroglycerin-Induced Hypersensitivity in Mice.

Authors:  Hui Shu; Sufang Liu; Yuanyuan Tang; Brian L Schmidt; John C Dolan; Larry L Bellinger; Phillip R Kramer; Steven D Bender; Feng Tao
Journal:  Int J Mol Sci       Date:  2020-06-05       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.